Business
GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
CHICAGO & SAN RAMON, Calif., May 13, 2025--GE HealthCare (Nasdaq: GEHC) and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and technology of the two companies to advance fetal oxygen saturation monitoring technology with the goal of enhancing the detection of fetal distress during childbirth.
About this update from Ge Healthcare Technologies Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":6570,"height":2242,"url":"https://media.zenfs.com/en/business-wire.com/9527fb3eced192d72c170586319d75e7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/eYSsy2UHJYHcnLxryGhtXg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/9527fb3eced192d72c170586319d75e7","width":960,"height":328},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/M8OHEQ2AcJkIqfcWqBheZg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/9527fb3eced192d72c170586319d75e7","width":1200,"height":409}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"The companies plan to co-develop solutions that support the integration of Raydiant Oximetry’s fetal pulse oximetry technology into GE HealthCare’s fetal monitoring and digital perinatal surveillance platforms that have a 60-year history of innovation and industry firsts.","length":272,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Fetal pulse oximetry technology aims to provide real-time insights to clinicians during labor and delivery and improve the detection of fetal distress, potentially reducing newborn neurological injuries, emergency cesarean sections and improving healthcare costs.","length":263,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Expanding fetal monitoring to include oxygen saturation could support clinicians in improving the standard of care by providing a more comprehensive view of fetal well-being.","length":174,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":709,"olType":false},{"type":"text","content":"CHICAGO & SAN RAMON, Calif., May 13, 2025--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and technology of the two companies to advance fetal oxygen saturation monitoring technology with the goal of enhancing the detection of fetal distress during childbirth.","length":500,"tagName":"p"},{"type":"text","content":"Incorporating oxygen saturation in...